Defining coronary restenosis. Newer clinical and angiographic paradigms.
1993; Lippincott Williams & Wilkins; Volume: 88; Issue: 3 Linguagem: Inglês
10.1161/01.cir.88.3.1310
ISSN1524-4539
AutoresRichard E. Kuntz, Donald S. Baim,
Tópico(s)Cardiovascular Function and Risk Factors
ResumoHomeCirculationVol. 88, No. 3Defining coronary restenosis. Newer clinical and angiographic paradigms. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBDefining coronary restenosis. Newer clinical and angiographic paradigms. R E Kuntz and D S Baim R E KuntzR E Kuntz Department of Medicine, Harvard Medical School, Boston, Mass. and D S BaimD S Baim Department of Medicine, Harvard Medical School, Boston, Mass. Originally published1 Sep 1993https://doi.org/10.1161/01.CIR.88.3.1310Circulation. 1993;88:1310–1323 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Yang J, Zheng Y, Li C, Liu Y, Zhou Q, Gao J, Meng X, Zhang K, Wang W, Shao C and Tang Y (2021) The Impact of Subclinical Hyperthyroidism on Cardiovascular Prognosis in Patients Undergoing Percutaneous Coronary Intervention, The Journal of Clinical Endocrinology & Metabolism, 10.1210/clinem/dgab855, 107:4, (986-997), Online publication date: 24-Mar-2022. Levent F, Senoz O, Emren S, Emren Z and Gediz R (2021) Is coronary artery tortuosity a predisposing factor for drug-eluting stent restenosis?Ist die Koronararterienschlängelung ein prädisponierender Faktor für die Restenose eines medikamentenfreisetzenden Stents?, Herz, 10.1007/s00059-021-05036-z, 47:1, (73-78), Online publication date: 1-Feb-2022. Sakamoto A, Sato Y, Kawakami R, Cornelissen A, Mori M, Kawai K, Fernandez R, Fuller D, Gadhoke N, Guo L, Romero M, Kolodgie F, Virmani R and Finn A (2021) Risk prediction of in-stent restenosis among patients with coronary drug-eluting stents: current clinical approaches and challenges, Expert Review of Cardiovascular Therapy, 10.1080/14779072.2021.1856657, 19:9, (801-816), Online publication date: 2-Sep-2021. Yoshimura M, Umemoto S, Kawano R, Hiromoto M, Yamada M, Fujimura T, Tanaka M, Nao T, Miura T and Yano M (2021) Non-Fasting Hypertriglyceridemia as an Independent Risk Factor for Coronary In-Stent Restenosis after Primary Bare Metal Stent Implantation in Patients with Coronary Artery Disease, International Heart Journal, 10.1536/ihj.21-015, 62:5, (970-979), Online publication date: 29-Sep-2021. Marino M, Vairo G and Wriggers P Mechano-chemo-biological Computational Models for Arteries in Health, Disease and Healing: From Tissue Remodelling to Drug-eluting Devices, Current Pharmaceutical Design, 10.2174/1381612826666200728145752, 27:16, (1904-1917) Mut F, Kapitan M and Beretta M (2021) Nuclear Techniques Before and After Coronary Revascularization Nuclear Cardiology, 10.1007/978-3-030-62195-7_12, (331-346), . Miguel J, Lechuga Y, Allende M and Martinez M (2020) Performance evaluation of CCOs for the optimization of low-power pressure-based implantable wireless systems, Microprocessors and Microsystems, 10.1016/j.micpro.2020.103273, 79, (103273), Online publication date: 1-Nov-2020. Sampedro-Gómez J, Dorado-Díaz P, Vicente-Palacios V, Sánchez-Puente A, Jiménez-Navarro M, San Roman J, Galindo-Villardón P, Sanchez P and Fernández-Avilés F (2020) Machine Learning to Predict Stent Restenosis Based on Daily Demographic, Clinical, and Angiographic Characteristics, Canadian Journal of Cardiology, 10.1016/j.cjca.2020.01.027, 36:10, (1624-1632), Online publication date: 1-Oct-2020. Miguel J, Lechuga Y, Allende M and Martinez M (2019) Optimization of CCOs with Implantable MEMS Pressure Sensors for Cardiovascular Applications 2019 22nd Euromicro Conference on Digital System Design (DSD), 10.1109/DSD.2019.00071, 978-1-7281-2862-7, (449-455) O'Sullivan J, Neylon A, Fahy E, Yang P, McGorrian C and Blake G (2019) MiR-93-5p is a novel predictor of coronary in-stent restenosis, Heart Asia, 10.1136/heartasia-2018-011134, 11:1, (e011134), Online publication date: 1-Feb-2019. Waksman R and Iantorno M (2018) Refractory In-Stent Restenosis: Improving Outcomes by Standardizing Our Approach, Current Cardiology Reports, 10.1007/s11886-018-1076-6, 20:12, Online publication date: 1-Dec-2018. Liu L, Liu J, Gao Q, Wu Y, Lu J, Wan J, Li Y, Cui X, Zhou K, Jia W, Huang Y, Qu W and Lin Q (2018) Effectiveness and Safety of Compound Chinese Medicine plus Routine Western Medicine in In-Stent Restenosis: A Meta-Analysis and Systematic Review, Evidence-Based Complementary and Alternative Medicine, 10.1155/2018/6207524, 2018, (1-27), Online publication date: 11-Jul-2018. Nicolais C, Lakhter V, Virk H, Sardar P, Bavishi C, O'Murchu B and Chatterjee S (2018) Therapeutic Options for In-Stent Restenosis, Current Cardiology Reports, 10.1007/s11886-018-0952-4, 20:2, Online publication date: 1-Feb-2018. Vesga B, Vásquez S and Hernández H (2017) Manejo de la reestenosis intrastent, Revista Colombiana de Cardiología, 10.1016/j.rccar.2017.11.010, 24, (84-90), Online publication date: 1-Dec-2017. Miguel J, Lechuga Y, Allende M and Martinez M (2017) CCO-based analog front-end for iStents 2017 32nd Conference on Design of Circuits and Integrated Systems (DCIS), 10.1109/DCIS.2017.8311643, 978-1-5386-5108-7, (1-6) Yang H, Wang C, Liu C, Chen H, Wu Y, Han J, Jia Z, Lin W, Zhang D, Li W, Yuan W, Guo H, Li H, Yang G, Kong D, Zhu D, Takashima K, Ruan L, Nie J, Li X and Zheng Y (2017) Evolution of the degradation mechanism of pure zinc stent in the one-year study of rabbit abdominal aorta model, Biomaterials, 10.1016/j.biomaterials.2017.08.022, 145, (92-105), Online publication date: 1-Nov-2017. Alraies M, Darmoch F, Tummala R and Waksman R (2017) Diagnosis and management challenges of in-stent restenosis in coronary arteries, World Journal of Cardiology, 10.4330/wjc.v9.i8.640, 9:8, (640), . Ucar F (2016) A potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratio, BMC Cardiovascular Disorders, 10.1186/s12872-016-0367-3, 16:1, Online publication date: 1-Dec-2016. Sharma G and Megaly M (2016) Etravirine as a culprit of recurrent drug-eluting in-stent restenosis in an HIV patient, International Journal of Cardiology, 10.1016/j.ijcard.2016.06.008, 219, (117-118), Online publication date: 1-Sep-2016. Elmore J, Mehanna E, Parikh S and Zidar D (2016) Restenosis of the Coronary Arteries, Interventional Cardiology Clinics, 10.1016/j.iccl.2016.03.002, 5:3, (281-293), Online publication date: 1-Jul-2016. Cassese S, Byrne R, Schulz S, Hoppman P, Kreutzer J, Feuchtenberger A, Ibrahim T, Ott I, Fusaro M, Schunkert H, Laugwitz K and Kastrati A (2014) Prognostic role of restenosis in 10 004 patients undergoing routine control angiography after coronary stenting, European Heart Journal, 10.1093/eurheartj/ehu383, 36:2, (94-99), Online publication date: 7-Jan-2015., Online publication date: 7-Jan-2015. d'Errico M, Sammarco P and Vairo G (2015) Analytical modeling of drug dynamics induced by eluting stents in the coronary multi-layered curved domain, Mathematical Biosciences, 10.1016/j.mbs.2015.06.016, 267, (79-96), Online publication date: 1-Sep-2015. Alfonso F, Byrne R, Rivero F and Kastrati A (2014) Current Treatment of In-Stent Restenosis, Journal of the American College of Cardiology, 10.1016/j.jacc.2014.02.545, 63:24, (2659-2673), Online publication date: 1-Jun-2014. Haine S, Van Craenenbroeck E, Hoymans V, Miljoen H, Vandendriessche T, Claeys M, Frederix G, Conraads V, Bosmans J and Vrints C (2014) Levels of Circulating CD34+/KDR+ Cells Do Not Predict Coronary In-Stent Restenosis, Canadian Journal of Cardiology, 10.1016/j.cjca.2013.10.012, 30:1, (102-108), Online publication date: 1-Jan-2014. Byrne R, Joner M, Alfonso F and Kastrati A (2013) Drug-coated balloon therapy in coronary and peripheral artery disease, Nature Reviews Cardiology, 10.1038/nrcardio.2013.165, 11:1, (13-23), Online publication date: 1-Jan-2014. Mehta S and Kleiman N (2013) Stable Angina Essential Cardiology, 10.1007/978-1-4614-6705-2_24, (419-438), . Xu B, Yang Y, Yuan Z, Du Z, Wong S, Généreux P and LU S (2013) Zotarolimus- and Paclitaxel-Eluting Stents in an All-Comer Population in China, JACC: Cardiovascular Interventions, 10.1016/j.jcin.2013.03.001, 6:7, (664-670), Online publication date: 1-Jul-2013. Croce K, Costa M and Simon D (2012) Restenosis Textbook of Interventional Cardiology, 10.1016/B978-1-4377-2358-8.00032-2, (421-431), . Zheng G, Liu J, Wang N, Chen H and Chu J (2012) Systematic Review of Chinese Herbal Medicines for Preventing in-Stent Coronary Restenosis after Percutaneous Coronary Intervention, Evidence-Based Complementary and Alternative Medicine, 10.1155/2012/253409, 2012, (1-19), . Wimmer N and Yeh R (2012) Another View of Personalized Medicine: Optimizing Stent Selection on the Basis of Predicted Benefit in Percutaneous Coronary Intervention, Trends in Cardiovascular Medicine, 10.1016/j.tcm.2012.06.006, 22:1, (23-28), Online publication date: 1-Jan-2012. Abou-Chebl A (2011) Intracranial Stenting With Wingspan, Stroke, 42:7, (1809-1811), Online publication date: 1-Jul-2011. Kim Y, Xu X and Lee J (2010) The Effect of Stent Porosity and Strut Shape on Saccular Aneurysm and its Numerical Analysis with Lattice Boltzmann Method, Annals of Biomedical Engineering, 10.1007/s10439-010-9994-5, 38:7, (2274-2292), Online publication date: 1-Jul-2010. Birkenhauer P, Yang Z and Gander B (2010) Preventing restenosis in early drug-eluting stent era: recent developments and future perspectives, Journal of Pharmacy and Pharmacology, 10.1211/0022357044797, 56:11, (1339-1356), Online publication date: 18-Feb-2010. Wong K, Thavornpattanapong P, Tu J, Chaichana T and Sun Z (2010) Analysis on intra-aneurysmal flow influence by stenting 2010 3rd International Conference on Biomedical Engineering and Informatics (BMEI), 10.1109/BMEI.2010.5639477, 978-1-4244-6498-2, (113-117) McNair E, Wells C, Mabood Qureshi A, Basran R, Pearce C, Orvold J, Devilliers J and Prasad K (2010) Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictor of Restenosis Following Percutaneous Coronary Intervention, Clinical Cardiology, 10.1002/clc.20815, 33:11, (678-685), Online publication date: 1-Nov-2010. POPMA J and ALMONACID A (2009) Angiographic Markers of Restenosis after Drug-Eluting Stent Implantation: Surrogates for Late Clinical Outcomes?, Journal of Interventional Cardiology, 10.1111/j.1540-8183.2009.00426.x, 22, (S64-S71), Online publication date: 1-Apr-2009. Meuwissen M, Siebes M, Chamuleau S, Verhoeff B, Henriques J, Spaan J and Piek J (2009) Role of fractional and coronary flow reserve in clinical decision making in intermediate coronary lesions, Interventional Cardiology, 10.2217/ica.09.33, 1:2, (237-255), Online publication date: 1-Dec-2009. Chen C (2009) Magnolol encapsulated by different acyl chain length of liposomes on inhibiting proliferation of smooth muscle cells, Journal of the Taiwan Institute of Chemical Engineers, 10.1016/j.jtice.2008.10.006, 40:4, (380-386), Online publication date: 1-Jul-2009. Holmes D, Firth B, Hodgson P, Rihal C, Wood D and Cohen D (2008) Evolving challenges in medical device evaluation, Catheterization and Cardiovascular Interventions, 10.1002/ccd.21541, 72:1, (1-6), Online publication date: 1-Jul-2008. Chen C and Wu C (2013) Magnolol Encapsulated by Liposome in Inhibiting Smooth Muscle Cell Proliferation, Journal of the Chinese Chemical Society, 10.1002/jccs.200800076, 55:3, (517-521), Online publication date: 1-Jun-2008. Chen C (2008) Inhibiting the vascular smooth muscle cells proliferation by EPC and DPPC liposomes encapsulated magnolol, Journal of the Chinese Institute of Chemical Engineers, 10.1016/j.jcice.2008.04.005, 39:5, (407-411), Online publication date: 1-Sep-2008. Artis L, Burkhart T, Johnson T and Matuszewski K (2006) Physician Factors as an Indicator of Technological Device Adoption, Journal of Medical Systems, 10.1007/s10916-005-8066-2, 30:3, (177-186), Online publication date: 1-Jun-2006. Chalela W, Kreling J, Falcão A, Hueb W, Moffa P, Pereyra P and Ramires J (2006) Exercise stress testing before and after successful multivessel percutaneous transluminal coronary angioplasty, Brazilian Journal of Medical and Biological Research, 10.1590/S0100-879X2006000400007, 39:4, (475-482), Online publication date: 1-Apr-2006. Smith S, Feldman T, Hirshfeld J, Jacobs A, Kern M, King S, Morrison D, O'Neill W, Schaff H, Whitlow P, Williams D, Antman E, Smith S, Adams C, Anderson J, Faxon D, Fuster V, Halperin J, Hiratzka L, Hunt S, Jacobs A, Nishimura R, Ornato J, Page R and Riegel B (2006) ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Journal of the American College of Cardiology, 10.1016/j.jacc.2005.12.001, 47:1, (e1-e121), Online publication date: 1-Jan-2006. Cutlip D (2006) Drug-eluting stent era: will we improve 5-year outcomes?, Coronary Artery Disease, 10.1097/00019501-200605000-00014, 17:3, (289-292), Online publication date: 1-May-2006. Ballyk P (2006) Intramural Stress Increases Exponentially with Stent Diameter: A Stress Threshold for Neointimal Hyperplasia, Journal of Vascular and Interventional Radiology, 10.1097/01.RVI.0000228361.23849.7F, 17:7, (1139-1145), Online publication date: 1-Jul-2006. Worthley M, Anderson T, Traboulsi M, Charbonneau F, Curtis M, Hansen J, Knudtson M, Spence F and Goodhart D (2006) Registry Data Evaluating the Effectiveness of Drug-eluting Stents for the Treatment of Symptomatic In-stent Restenosis, Heart, Lung and Circulation, 10.1016/j.hlc.2006.06.002, 15:5, (300-305), Online publication date: 1-Oct-2006. Cutlip D (2006) Drug-eluting stent era: will we improve 5-year outcomes?, Coronary Artery Disease, 10.1097/01.mca.0000196795.77492.bc, 17:8, (681-684), Online publication date: 1-Dec-2006. Atmakuri S, Gollob M and Kleiman N Stable Angina Essential Cardiology, 10.1007/978-1-59259-918-9_25, (451-470) Pokrajac B, Minar E, Kirisits C and Pötter R Vascular Brachytherapy New Technologies in Radiation Oncology, 10.1007/3-540-29999-8_30, (389-395) Muni N, Califf R, Foy J, Boam A, Zuckerman B and Kuntz R (2005) Coronary drug-eluting stent development: Issues in trial design, American Heart Journal, 10.1016/j.ahj.2004.09.001, 149:3, (415-433), Online publication date: 1-Mar-2005. Kereiakes D, Kuntz R, Mauri L and Krucoff M (2005) Surrogates, substudies, and real clinical end points in trials of drug-eluting stents**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology., Journal of the American College of Cardiology, 10.1016/j.jacc.2005.01.005, 45:8, (1206-1212), Online publication date: 1-Apr-2005. Martí V, Romeo I, Kozak F, García-Picart J, Guiteras P, García-Arriaga J, Puntí J and Augé J (2005) Neointimal Tissue Proliferation After Coronary Stent Implantation Without Predilatation, Revista Española de Cardiología (English Edition), 10.1016/S1885-5857(06)60437-4, 58:9, (1045-1053), Online publication date: 1-Sep-2005. Martí V, Romeo I, Kozak F, García-Picart J, Guiteras P, García-Arriaga J, Puntí J and Augé J (2005) Proliferación neointimal después de la implantación coronaria de stent sin predilatación, Revista Española de Cardiología, 10.1157/13078552, 58:9, (1045-1053), Online publication date: 1-Sep-2005. Moreno R (2005) Stents recubiertos y otros dispositivos antirreestenosis, Revista Española de Cardiología, 10.1157/13077236, 58:7, (842-862), Online publication date: 1-Jul-2005. Moreno R (2005) Drug-Eluting Stents and Other Anti-Restenosis Devices, Revista Española de Cardiología (English Edition), 10.1016/S1885-5857(06)60513-6, 58:7, (842-862), Online publication date: 1-Jul-2005. Mauri L, O'Malley A, Cutlip D, Ho K, Popma J, Chauhan M, Baim D, Cohen D and Kuntz R (2004) Effects of stent length and lesion length on coronary restenosis, The American Journal of Cardiology, 10.1016/j.amjcard.2004.02.027, 93:11, (1340-1346), Online publication date: 1-Jun-2004. Baim D (2004) New devices for percutaneous coronary intervention are rapidly making bypass surgery obsolete, Current Opinion in Cardiology, 10.1097/01.hco.0000142065.37837.b4, 19:6, (593-597), Online publication date: 1-Nov-2004. Ahmed J, Mintz G, Waksman R, Castagna M, Canos D, Satler L, Kent K, Pichard A and Weissman N (2003) Serial volumetric intravascular ultrasound assessment of native coronary artery versus saphenous vein grafts in-stent restenosis lesions after conventional catheter-based treatment, The American Journal of Cardiology, 10.1016/S0002-9149(02)03419-7, 91:6, (739-741), Online publication date: 1-Mar-2003. Dori G, Denekamp Y, Fishman S and Bitterman H (2003) Exercise stress testing, myocardial perfusion imaging and stress echocardiography for detecting restenosis after successful percutaneous transluminal coronary angioplasty: a review of performance, Journal of Internal Medicine, 10.1046/j.1365-2796.2003.01101.x, 253:3, (253-262), Online publication date: 1-Mar-2003. Greenberg D, Bakhai A and Cohen D (2003) Do the Benefits of New Technology Outweigh the Costs?, American Journal of Drug Delivery, 10.2165/00137696-200301040-00004, 1:4, (255-266), . Colombo A (2003) Influence of residual stenosis after coronary stent implantation on development of restenosis and stent thrombosis, The American Journal of Cardiology, 10.1016/S0002-9149(03)00789-6, 92:8, (1013), Online publication date: 1-Oct-2003. Zellweger M, Weinbacher M, Zutter A, Jeger R, Mueller-Brand J, Kaiser C, Buser P and Pfisterer M (2003) Long-term outcome of patients with silent versus symptomatic ischemia six months after percutaneous coronary intervention and stenting, Journal of the American College of Cardiology, 10.1016/S0735-1097(03)00557-6, 42:1, (33-40), Online publication date: 1-Jul-2003. Sick P, Hüttl T, Niebauer J, Thiele H, Lauer B, Hambrecht R, Hentschel B and Schuler G (2003) Reply: influence of residual stenosis after coronary stent implantation on development of restenosis and stent thrombosis, The American Journal of Cardiology, 10.1016/S0002-9149(03)00790-2, 92:8, (1013-1014), Online publication date: 1-Oct-2003. Alfke H, Froelich J, Nowak S and Wagner H (2016) Cardiovascular Risk Factors Do Not Predict Clinically Defined Restenosis After Percutaneous Transluminal Angioplasty for Lower Limb Ischemia, Angiology, 10.1177/000331970205300103, 53:1, (15-20), Online publication date: 1-Jan-2002. Newby L, Alpert J, Ohman E, Thygesen K and Califf R (2002) Changing the diagnosis of acute myocardial infarction: Implications for practice and clinical investigations, American Heart Journal, 10.1067/mhj.2002.129778, 144:6, (957-980), Online publication date: 1-Dec-2002. Cutlip D, Chauhan M, Baim D, Ho K, Popma J, Carrozza J, Cohen D and Kuntz R (2002) Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials, Journal of the American College of Cardiology, 10.1016/S0735-1097(02)02597-4, 40:12, (2082-2089), Online publication date: 1-Dec-2002. Kao H, Lin L, Wu C, Liau C and Lee Y (2002) Suppression of Cyclic Coronary Flow Variation and Reduction of Restenosis with Abciximab for Morphologically High-Risk Lesions Undergoing Percutaneous Coronary Intervention, Journal of Cardiovascular Pharmacology, 10.1097/00005344-200206000-00016, 39:6, (901-908), Online publication date: 1-Jun-2002. Gibson C, Dotani M, Murphy S, Marble S, Dauterman K, Michaels A and Dodge J (2002) Correlates of coronary blood flow before and after percutaneous coronary intervention and their relationship to angiographic and clinical outcomes in the RESTORE trial, American Heart Journal, 10.1067/mhj.2002.123142, 144:1, (130-135), Online publication date: 1-Jul-2002. Mauri L, Bonan R, Weiner B, Legrand V, Bassand J, Popma J, Niemyski P, Prpic R, Ho K, Chauhan M, Cutlip D, Bertrand O and Kuntz R (2002) Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized Trial, The American Journal of Cardiology, 10.1016/S0002-9149(02)02773-X, 90:10, (1079-1083), Online publication date: 1-Nov-2002. Hehrlein C (2002) Strategien zur Verhinderung der Restenose nach Katheterintervention Kardiovaskuläre Strahlentherapie, 10.1007/978-3-642-96011-6_2, (13-31), . Martí V, Romeo I, García J, Guiteras P, Aminian N and Augé J (2001) Twelve-month outcome after coronary stent implantation without predilatation, The American Journal of Cardiology, 10.1016/S0002-9149(01)01854-9, 88:7, (788-792), Online publication date: 1-Oct-2001. Smith S, Dove J, Jacobs A, Ward Kennedy J, Kereiakes D, Kern M, Kuntz R, Popma J, Schaff H, Williams D, Gibbons R, Alpert J, Eagle K, Faxon D, Fuster V, Gardner T, Gregoratos G, Russell R and Smith S (2001) ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)31This document was approved by the American College of Cardiology Board of Trustees in April 2001 and by the American Heart Association Science Advisory and Coordinating Committee in March 2001.32When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following citation format: Smith SC, Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO. ACC/AHA guidelines for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 2001;37:2239i–lxvi.33This document is available on the ACC Web site at www.acc.organd the AHA Web site at www.americanheart.org(ask for reprint no. 71-0206). To obtain a reprint of the shorter version (executive summary and summary of recommendations) to be published in the June 15, 2001 issue of the Journal of the American College of Cardiology and the June 19, 2001 issue of Circulation for $5 each, call 800-253-4636 (US only) or write the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. To purchase additional reprints up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1,000 or more copies, call 214-706-1466, fax 214-691-6342, or E-mail: [email protected](ask for reprint no. 71-0205)., Journal of the American College of Cardiology, 10.1016/S0735-1097(01)01345-6, 37:8, (2239), Online publication date: 1-Jun-2001. Gershlick A (2001) Role of stenting in coronary revascularisation, Heart, 10.1136/hrt.86.1.104, 86:1, (104-112), Online publication date: 1-Jul-2001. Bennett M and O'Sullivan M (2001) Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy, Pharmacology & Therapeutics, 10.1016/S0163-7258(01)00153-X, 91:2, (149-166), Online publication date: 1-Aug-2001. Couffinhal T, Dufourcq P, Jaspard B, Daret D, Allières C, Alzieu P, Serre P, Bonnet J and Duplàa C (2001) Kinetics of adventitial repair in the rat carotid model, Coronary Artery Disease, 10.1097/00019501-200112000-00007, 12:8, (635-648), Online publication date: 1-Dec-2001. Urasawa K, Kaneta S, Nakano N, Saito T, Sakai H, Takagi C, Takagi Y, Sugiki H and Kitabatake a (2001) Vascular Smooth Muscle Cell Proliferation is Effectively Suppressed by the Non-specific Growth Factor Inhibitor Suramin, Japanese Heart Journal, 10.1536/jhj.42.221, 42:2, (221-233), . Mercado N, Boersma E, Wijns W, Gersh B, Morillo C, de Valk V, van Es G, Grobbee D and Serruys P (2001) Clinical and quantitative coronary angiographic predictors of coronary restenosis, Journal of the American College of Cardiology, 10.1016/S0735-1097(01)01431-0, 38:3, (645-652), Online publication date: 1-Sep-2001. Signore P, Machan L, Jackson J, Burt H, Bromley P, Wilson J and McManus B (2001) Complete Inhibition of Intimal Hyperplasia by Perivascular Delivery of Paclitaxel in Balloon-injured Rat Carotid Arteries, Journal of Vascular and Interventional Radiology, 10.1016/S1051-0443(07)61408-0, 12:1, (79-88), Online publication date: 1-Jan-2001. Jørgensen B, Simonsen S, Endresen K, Forfang K, Egeland T and Thaulow E (2000) Physiologic response to gain and loss in coronary minimal luminal diameter in patients treated with coronary angioplasty: Prediction of restenosis on the basis of exercise capacity, American Heart Journal, 10.1016/S0002-8703(00)90092-9, 139:3, (482-490), Online publication date: 1-Mar-2000. Uretsky B, Rosanio S, Lerakis S, Wang F, Smiley M, Stouffer G, Tocchi M and Estella P (2000) A prospective evaluation of angiography-guided coronary stent implantation with high versus very high balloon inflation pressure, American Heart Journal, 10.1067/mhj.2000.110572, 140:5, (804-812), Online publication date: 1-Nov-2000. Baim D (2000) Is it time to offer elective percutaneous treatment of the unprotected left main coronary artery?∗∗Editorials published in Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology., Journal of the American College of Cardiology, 10.1016/S0735-1097(00)00598-2, 35:6, (1551-1553), Online publication date: 1-May-2000. Motwani J, Raymond R, Franco I, Ellis S and Whitlow P (2000) Effectiveness of rotational atherectomy of right coronary artery ostial stenosis, The American Journal of Cardiology, 10.1016/S0002-9149(99)00812-7, 85:5, (563-567), Online publication date: 1-Mar-2000. Crowe J, Shapo B, Stephens D, Bleam D, Eberle M, Ignacio Cespedes E, Ching-Chen Wu , Muller D, Kovach J, Lederman R and O'Donnell M Blood speed imaging with an intraluminal array, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control, 10.1109/58.842055, 47:3, (672-681) Mart� V, Salas E, Aymat R, Garc�a J, Guiteras P, Romeo I, Kozak F and Aug� J (2000) Influence of residual stenosis in determining restenosis after cutting balloon angioplasty, Catheterization and Cardiovascular Interventions, 10.1002/(SICI)1522-726X(200004)49:4 3.0.CO;2-X, 49:4, (410-414), Online publication date: 1-Apr-2000. Pokrajac B, Pötter R, Maca T, Fellner C, Mittlböck M, Ahmadi R, Seitz W and Minar E (2000) Intraarterial 192Ir high-dose-rate brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2-trial radiotherapy parameters and risk factors analysis, International Journal of Radiation Oncology*Biology*Physics, 10.1016/S0360-3016(00)00716-1, 48:4, (923-931), Online publication date: 1-Nov-2000. Hehrlein C (2000) Strategien zur Verhinderung der Rezidivstenose nach Katheterintervention Kardiovaskuläre Strahlentherapie, 10.1007/978-3-662-22062-7_2, (13-31), . Bauriedel G, Hutter R, Welsch U and Lüderitz B Apoptosis in human atherosclerosis Apoptosis in Cardiac Biology, 10.1007/978-0-585-38143-5_15, (223-236) Fabbiocchi F, Bartorelli A, Montorsi P, Cozzi S, Trabattoni D, Calligaris G and Loaldi A (2000) Elective coronary stent implantation in cardiogenic shock complicating acute myocardial infarction: In-hospital and six-month clinical and angiographic results, Catheterization and Cardiovascular Interventions, 10.1002/1522-726X(200008)50:4 3.0.CO;2-K, 50:4, (384-389), Online publication date: 1-Aug-2000. INOUE T, HOSHI K, YAGUCHI I, MIYAKE Y, SHIMIZU M and MOROOKA S (2000) Cutting Balloon Angioplasty for Ostial Lesions of the Left Anterior Descending Artery, Journal of Interventional Cardiology, 10.1111/j.1540-8183.2000.tb00689.x, 13:1, (7-13), Online publication date: 1-Feb-2000. Inoue T, Sohma R, Miyazaki T, Iwasaki Y, Yaguchi I and Morooka S (2000) Comparison of activation process of platelets and neutrophils after coronary stent implantation versus balloon angioplasty for stable angina pectoris, The American Journal of Cardiology, 10.1016/S0002-9149(00)01159-0, 86:10, (1057-1062), Online publication date: 1-Nov-2000. Saucedo J, Popma J, Kennard E, Talley J, Lansky A, Leon M and Baim D (2000) Relation of coronary artery size to one-year clinical events after new device angioplasty of native coronary arteries (a New Approach to Coronary Intervention [NACI] Registry report), The American Journal of Cardiology, 10.1016/S0002-9149(99)00649-9, 85:2, (166-171), Online publication date: 1-Jan-2000. Panning C (2016) Antithrombotic Therapy during and after Intracoronary Stenting, Journal of Pharmacy Technology, 10.1177/875512250001600502, 16:5, (185-196), Online publication date: 1-Sep-2000. Beygui F, Le Feuvre C, Maunoury C, Helft G, Antonietti T, Metzger J and Vacheron A (2000) Detection of coronary restenosis by exercise electrocardiography thallium-201 perfusion imaging and coronary angiography in asymptomatic patients after percutaneous transluminal coronary angioplasty, The American Journal of Cardiology, 10.1016/S0002-9149(00)00825-0, 86:1, (35-40), Online publication date: 1-Jul-2000. Cannan C, Yeh W, Kelsey S, Cohen H, Detre K and Williams D (1999) Incidence and predictors of target vessel revascularization following percutaneous transluminal coronary angioplasty: a report from the national heart, lung, and blood institute percutaneous transluminal coronary angioplasty registry, The American Journal of Cardiology, 10.1016/S0002-9149(99)00229-5, 84:2, (170-175), Online publication date: 1-Jul-1999. Dangas G and Mehran R (1999) Restenosis Contemporary Concepts in Cardiology, 10.1007/978-1-4615-5007-5_32, (521-537), . Meyer B, Badimon L and Chesebro J (1999) Syndromes of Accelerated Atherosclerosis Contemporary Concepts in Cardiology, 10.1007/978-1-4615-5007-5_2, (19-27), . Hardt S, Bekeredjian R, Brachmann J, Kuecherer H, Hansen A, K�bler W and Katus H (1999) Intravascular ultrasound for evaluation of initial vessel patency and early outcome following directional coronary atherectomy, Catheterization and Cardiovascular Interventions, 10.1002/(SICI)1522-726X(199905)47:1 3.0.CO;2-6, 47:1, (14-22), Online publication date: 1-May-1999. Köster R, Hamm C, Seabra-Gomes R, Her
Referência(s)